Streetbeat News

Revenues

FHN

First Horizon (NYSE:FHN) reported Q2 2024 sales of $815 million, missing the analyst consensus estimate of $822.032 million by 0.86%. This represents a 20.95% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:33 am

JNJ

Johnson & Johnson has raised its 2024 operational sales forecast to $89.2 billion-$89.6 billion, up from the previous guidance of $88.7 billion-$89.1 billion. The company also reaffirmed its 2024 reported sales guidance of $88 billion-$88.4 billion, which is in line with the consensus estimate of $88.74 billion.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:28 am

JNJ

Johnson & Johnson reported Q2 2024 adjusted EPS of $2.82, beating the estimate of $2.70. Sales were $22.447 billion, surpassing the expected $22.306 billion.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:22 am

SYF

Synchrony Financial reported a Q2 net interest income of $4.41 billion, which is a 7% decrease year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:10 am

SYF

Synchrony Financial reported a 1% decrease in Q2 purchase volume, an 81% increase in loan receivables, and a 48 basis points decrease in net interest margin.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:08 am

ELV

Elevance Health reported a Q2 total medical membership of 45.78 million, down 5% year-over-year. However, the benefit expense ratio improved by 10 basis points to 86.3%.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:04 am

XPO

XPO has announced a significant expansion of its cross-border service between the US and Mexico with the launch of XPO Mexico+. This expansion includes increased capacity, coverage, and technology enhancements to meet growing customer demand as supply chains shift to North American production.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:02 am

SYF

Synchrony Financial (NYSE:SYF) reported Q2 2024 GAAP EPS of $1.55, beating the analyst estimate of $1.36 by 13.97%. The company also reported sales of $4.405 billion, surpassing the $4.287 billion estimate by 2.75%. This represents a 6.92% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:01 am

ELV

Elevance Health reported Q2 2024 adjusted EPS of $10.12, beating the estimate of $10.01. Sales were $43.223 billion, also surpassing the estimate of $43.054 billion.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 10:01 am

IYE

XLE

XOM

Exxon Mobil Corporation (NYSE:XOM) shut down its Joliet, Illinois refinery due to a power outage caused by a storm. The refinery processes Canadian crude oil and produces around 9 million gallons of gasoline and diesel per day. Exxon also announced plans to drill up to 30 wells for its Hammerhead project in Guyana, expected to produce 120,000-180,000 barrels of crude daily. Exxon will report Q2 FY24 results on August 2, 2024. Investors can gain exposure to Exxon via Energy Select Sector SPDR Fund (NYSE:XLE) and IShares U.S. Energy ETF (NYSE:IYE).

Portfolio Pulse from Lekha Gupta

July 17, 2024 | 10:00 am